Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 76101-76150 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05742425
Serplulimab Combined With FOLFIRI and Bevacizumab in the Treatment of Colon Cancer Peritoneal Metastases
PHASE2Recruiting
30 participants
Started: Mar 31, 2023 · Completed: Mar 31, 2028
2 conditions2 sponsors1 location
NCT05751512
A Study to Evaluate MRG003 vs Cetuximab/Methotrexate in in the Treatment of Patients With RM-SCCHN
PHASE3Not yet recruiting
180 participants
Started: Mar 31, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06266039
Introduction of Long Acting Buprenorphine in France
N/ARecruiting
223 participants
Started: Mar 31, 2023 · Completed: Sep 30, 2024
1 condition1 sponsor1 location
NCT03862430
A Study of NanO2™ Combined With Radiation and Temozolomide in Patients With Newly Diagnosed GBM
PHASE2Active, not recruiting
87 participants
Started: Mar 31, 2023 · Completed: Sep 30, 2026
1 condition1 sponsor12 locations
NCT05468567
Three-dimensional Perception of Sounds in Military with Acoustic Trauma
N/ARecruiting
46 participants
Started: Mar 31, 2023 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT05604638
Early Administration of Tirofiban in Patients Treated With Tenecteplase for Acute Ischemic Stroke
PHASE4Not yet recruiting
600 participants
Started: Mar 31, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors0 locations
NCT05590871
FlashPoint Renal Denervation Under Columbus 3D Mapping System Guidance for Treating Hypertension
NARecruiting
180 participants
Started: Mar 31, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor27 locations
NCT05687942
The REBUILD Trial: Closure of the Abdominal Wall
NANot yet recruiting
40 participants
Started: Mar 31, 2023 · Completed: Jun 30, 2026
1 condition2 sponsors1 location
NCT05519670
A Phase 1b/2 Trial Evaluating Safety and Efficacy of CAPecitabine in Combination With Ni-rapaRIb in HER2-negative Advanced Breast canCEr
PHASE1/PHASE2Not yet recruiting
72 participants
Started: Mar 31, 2023 · Completed: Dec 31, 2027
1 condition2 sponsors0 locations
NCT05778149
Safety and Efficacy of Aumolertinib Combined With Anlotinib as 1st Line Treatment in Advanced Lung Cancer EGFR Mutation With TP53 Co-Mutation
PHASE2Not yet recruiting
47 participants
Started: Mar 31, 2023 · Completed: Mar 31, 2027
5 conditions1 sponsor0 locations
NCT05883696
Palliative Care Needs Among Elderly People at Emergency Department
N/ARecruiting
300 participants
Started: Mar 31, 2023 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT05754008
Care Navigator Support for Younger Latinx Adults With Type 2 Diabetes
NARecruiting
204 participants
Started: Mar 31, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06350656
Study of Cerebral Compliance in Neurosurgical Intensive Care Units (EC2)
N/ARecruiting
30 participants
Started: Mar 31, 2023 · Completed: Apr 30, 2024
1 condition1 sponsor7 locations
NCT05774145
Dexmeditomedine Versus No Sedation in Management of Agitation in COPD Patients Receiving Noninvasive Ventilation
N/ANot yet recruiting
80 participants
Started: Mar 31, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor0 locations
NCT05683587
Effect of Ballet Course on Lower Limb Strength, Balance, Working Memory and the Compliance and Satisfaction
NARecruiting
30 participants
Started: Mar 31, 2023 · Completed: Dec 31, 2025
6 conditions1 sponsor1 location
NCT05536310
TAVIS Registry - Trilogy Heart Valve System for Management of Patients With Aortic Valve Disease
N/ANot yet recruiting
600 participants
Started: Mar 31, 2023 · Completed: Oct 31, 2027
9 conditions1 sponsor3 locations
NCT05746104
Second Window Indocyanine Green for All Nervous System Tumors
PHASE1Enrolling by invitation
105 participants
Started: Mar 31, 2023 · Completed: Feb 15, 2027
1 condition1 sponsor1 location
NCT05204368
Evaluation of the Efficacy and Safety of Intravenous Imipenem/Cilastatin/XNW4107 in Comparison With Meropenem in Hospitalized Adults With cUTI Including AP (EudraCT no. 2022-000061-40)
PHASE3Not yet recruiting
780 participants
Started: Mar 30, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05795699
A Study to Evaluate the Safety and Efficacy of K-321 Eye Drops After Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD)
PHASE3Active, not recruiting
107 participants
Started: Mar 30, 2023 · Completed: Mar 31, 2026
1 condition1 sponsor50 locations
NCT04806399
Improving Utilization of Lung Cancer Screening in Underserved PA Populations
NAActive, not recruiting
2,500 participants
Started: Mar 30, 2023 · Completed: Nov 30, 2024
1 condition2 sponsors2 locations
NCT05741333
In-Office Clinical Study of the Solo+ TTD
NARecruiting
66 participants
Started: Mar 30, 2023 · Completed: Jun 30, 2027
2 conditions1 sponsor7 locations
NCT05727904
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
PHASE3Recruiting
670 participants
Started: Mar 30, 2023 · Completed: Mar 1, 2030
3 conditions1 sponsor72 locations
NCT05749588
FUSCC Refractory TNBC Platform Study (FUTURE2.0)
PHASE2Recruiting
120 participants
Started: Mar 30, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05568680
SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
PHASE1Recruiting
42 participants
Started: Mar 30, 2023 · Completed: Dec 31, 2027
3 conditions1 sponsor4 locations
NCT05732974
A Machine Learning Approach to Identify Patients With Resected Non-small-cell Lung Cancer With High Risk of Relapse
N/ARecruiting
60 participants
Started: Mar 30, 2023 · Completed: Oct 30, 2026
1 condition1 sponsor1 location
NCT05815602
Ebastine Versus Mebeverine in IBS Patients
PHASE3Recruiting
200 participants
Started: Mar 30, 2023 · Completed: Jan 1, 2028
2 conditions2 sponsors5 locations
NCT05790850
Pre-Habilitation with Mindfulness and Exercise for Patients Undergoing Radical Cystectomy (PRIMER Trial)
NARecruiting
30 participants
Started: Mar 30, 2023 · Completed: Jun 30, 2026
3 conditions3 sponsors1 location
NCT05488093
Evaluation of Mobility in Subjects With Severe Knee Osteoarthritis Who Are to Undergo Total Knee Replacement
NARecruiting
20 participants
Started: Mar 30, 2023 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT05691166
Reducing Falls With Progressive Resistance Training for the Oldest Old Adults With Sarcopenia
NAEnrolling by invitation
240 participants
Started: Mar 30, 2023 · Completed: Aug 30, 2026
2 conditions1 sponsor1 location
NCT05862558
Intravascular Lithotripsy in High Risk Calcified Iliac Anatomy for Transfemoral TAVR
N/ARecruiting
50 participants
Started: Mar 30, 2023 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT05546346
Clinical Application of Wearable Magnet Tracking System for Capsule Endoscopes
NARecruiting
10 participants
Started: Mar 30, 2023 · Completed: Oct 30, 2025
1 condition1 sponsor1 location
NCT05549414
Pivotal Study of Proton Radiotherapy Treatments Using Fixed Beam Chair-Based Delivery System
NARecruiting
100 participants
Started: Mar 30, 2023 · Completed: Feb 28, 2026
5 conditions2 sponsors1 location
NCT05653336
PerQseal® Clinical Study
NAActive, not recruiting
149 participants
Started: Mar 30, 2023 · Completed: Jun 30, 2025
1 condition1 sponsor18 locations
NCT05215171
World Trade Center Particulate Matter Induced Cardiorespiratory and Vascular Dysfunction: a MultiOmic Approach (CaRVD)
N/ARecruiting
100 participants
Started: Mar 30, 2023 · Completed: Jun 30, 2027
2 conditions2 sponsors1 location
NCT05467670
Safety and Efficacy of Anti-CD47, ALX148 in Combination with Liposomal Doxorubicin and Pembrolizumab in Recurrent Platinum-resistant Ovarian Cancer
PHASE2Recruiting
31 participants
Started: Mar 30, 2023 · Completed: Dec 31, 2031
1 condition3 sponsors1 location
NCT05780567
Clinical Study on Adjuvant Therapy of TQB3616 Combined With Endocrine Therapy Compared With Placebo Combined With Endocrine Therapy in Patients With Breast Cancer
PHASE3Recruiting
1,946 participants
Started: Mar 30, 2023 · Completed: Jan 31, 2027
1 condition1 sponsor3 locations
NCT05515237
Constraint-Induced Movement Therapy Plus Sensory Components After Stroke
NARecruiting
15 participants
Started: Mar 30, 2023 · Completed: Jun 30, 2026
3 conditions1 sponsor1 location
NCT05826600
A Study of OMX-0407 in Patients With Previously Treated Solid Tumours That Can't be Removed Surgically
PHASE1/PHASE2Recruiting
188 participants
Started: Mar 30, 2023 · Completed: Apr 30, 2026
1 condition1 sponsor15 locations
NCT05432791
Testing Olaparib and Temozolomide Versus the Usual Treatment for Uterine Leiomyosarcoma After Chemotherapy Has Stopped Working
PHASE2/PHASE3Active, not recruiting
190 participants
Started: Mar 30, 2023 · Completed: Mar 9, 2030
5 conditions1 sponsor145 locations
NCT05335187
Hybrid Micro-macro Electrodes in Patients with Epilepsy
NARecruiting
30 participants
Started: Mar 30, 2023 · Completed: Sep 30, 2027
1 condition3 sponsors2 locations
NCT06290817
Orelabrutinib Combined With R-CDOP for DLBCL Patients With High-risk of CNS Relapse Defined by CNS-IPI
PHASE2Recruiting
62 participants
Started: Mar 30, 2023 · Completed: Mar 20, 2026
1 condition6 sponsors6 locations
NCT05759793
A Study of CAR-GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia
PHASE1Recruiting
12 participants
Started: Mar 30, 2023 · Completed: Oct 1, 2026
2 conditions2 sponsors1 location
NCT04962711
Risk-guided Disease Management Plan to Prevent Heart Failure in Patients Treated With Previous Chemotherapy (REDEEM)
NARecruiting
685 participants
Started: Mar 30, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05845554
Application of Chromosomal Instability in Early Diagnosis of Biliary Tract Carcinoma
N/ARecruiting
300 participants
Started: Mar 30, 2023 · Completed: Apr 1, 2024
1 condition4 sponsors4 locations
NCT05432089
The Effects of Oxytocin Administration to Patients and Therapists on Physiological Synchronization
PHASE2Recruiting
120 participants
Started: Mar 30, 2023 · Completed: Jul 1, 2026
1 condition1 sponsor1 location
NCT05933239
Macrophage Imaging Using Ga-MMR-VHH2 in Lung Cancer Patients
PHASE2Recruiting
20 participants
Started: Mar 30, 2023 · Completed: Apr 1, 2027
1 condition1 sponsor1 location
NCT06061614
Safety and Efficacy Study of NGGT002 in PKU Adult Subjects
EARLY_PHASE1Recruiting
9 participants
Started: Mar 30, 2023 · Completed: Dec 30, 2028
1 condition1 sponsor1 location
NCT05837143
Myocardial Telomere Recapping Study for Dilated Cardiomyopathy
EARLY_PHASE1Active, not recruiting
12 participants
Started: Mar 30, 2023 · Completed: Dec 30, 2025
2 conditions2 sponsors1 location
NCT06026904
The Effects of taVNS on Motivation in MDD With Anhedonia
NAEnrolling by invitation
60 participants
Started: Mar 30, 2023 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT06723964
A Study of AP505 Injection in Patients With Advanced Malignant Solid Tumors
PHASE1Active, not recruiting
35 participants
Started: Mar 30, 2023 · Completed: Nov 30, 2025
1 condition1 sponsor1 location